A Mono-Center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions.

Trial Profile

A Mono-Center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2011

At a glance

  • Drugs Cilostazol (Primary)
  • Indications Arterial occlusive disorders; Embolism and thrombosis; Intermittent claudication; Stroke
  • Focus Pharmacokinetics
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 03 Mar 2009 Actual patient number (44) added as reported by ClinicalTrials.gov.
    • 03 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 03 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top